Decreased DNA Integrity [PE] - N0000008576

Name: Table of NDC products with decreased dna integrity
Creator: U.S. Food & Drug Administration
License: https://creativecommons.org/licenses/by-nc-sa/4.0/

Pharmacologic Class Information

Pharmacologic Code	N0000008576
Pharmacologic Name	Decreased DNA Integrity
Pharmacologic Uses	CD22-directed antibody-drug conjugate (ADC)
Pharmacologic Concept	Physiologic Effects - [PE]
Pharmacologic Concept Description	This concept refers to the tissue, organ, or organ system effects of drug generic ingredients, organized into an organ system classification hierarchy, beneath the "Physiological Effects [PE]" concept.

NDC Products with Decreased DNA Integrity

The table contains 1 products whose active ingredient are classified under the same pharmacologic class Decreased DNA Integrity [PE].

	NDC	Proprietary Name	Non-Proprietary Name	Dosage Form	Route Name	Company Name	Status
	0008-0100	Besponsa	Non-Proprietary Name: Inotuzumab Ozogamicin	Injection, Powder, Lyophilized, For Solution	Intravenous	Wyeth Pharmaceuticals Llc, A Subsidiary Of Pfizer Inc.	ACTIVE